PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB)

CUSIP: 71715X203

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
+1,928,548
Put/Call ratio
431%
SEC-reported price per share
$2.50
Number of holders
19
Value change
+$4,798,113
Number of buys
11
Open additional details 1 more signal available
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
10,666,413

Security key

71715X203

Report period

Q4 2021

Institutions

19

Top holders

10

Ownership snapshot

Top reported holders of PMCB - PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F Lead comparable stake: 9.5% Showing 1-6 of 15 holder rows.

Quick read

SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 9.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SABBY MANAGEMENT, LLC's linked filing trail.
Comparable ownership Top 5
SABBY MANAGEMENT, LLC 9.5%
PRICE T ROWE ASSOCIATES INC /MD/ 1.3%
Schonfeld Strategic Advisors LLC 0.83%
SUSQUEHANNA FUNDAMENTAL INVESTMEN... 0.47%
GEODE CAPITAL MANAGEMENT, LLC 0.44%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SABBY MANAGEMENT, LLC
13F
Company
13F
9.5%
$3,202,000
1,010,146 shares
30 Sep 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
1.3%
$424,000
133,600 shares
30 Sep 2021
Schonfeld Strategic Advisors LLC
13F
Company
13F
0.83%
$280,000
88,200 shares
30 Sep 2021
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
13F
0.47%
$158,000
49,700 shares
30 Sep 2021
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.44%
$147,000
46,610 shares
30 Sep 2021
NorthRock Partners, LLC
13F
Company
13F
0.35%
$118,000
37,164 shares
30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
19
Shares
3,469,931
Rows available
19
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
14
Q4 2021 holders
19
Holder diff
5
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .